1. Home
  2. XLO vs BGFV Comparison

XLO vs BGFV Comparison

Compare XLO & BGFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XLO
  • BGFV
  • Stock Information
  • Founded
  • XLO 2016
  • BGFV 1955
  • Country
  • XLO United States
  • BGFV United States
  • Employees
  • XLO N/A
  • BGFV N/A
  • Industry
  • XLO Biotechnology: Pharmaceutical Preparations
  • BGFV Other Specialty Stores
  • Sector
  • XLO Health Care
  • BGFV Consumer Discretionary
  • Exchange
  • XLO Nasdaq
  • BGFV Nasdaq
  • Market Cap
  • XLO 43.5M
  • BGFV 47.2M
  • IPO Year
  • XLO 2021
  • BGFV N/A
  • Fundamental
  • Price
  • XLO $0.89
  • BGFV $1.71
  • Analyst Decision
  • XLO Buy
  • BGFV
  • Analyst Count
  • XLO 1
  • BGFV 0
  • Target Price
  • XLO $4.00
  • BGFV N/A
  • AVG Volume (30 Days)
  • XLO 466.7K
  • BGFV 267.8K
  • Earning Date
  • XLO 11-07-2024
  • BGFV 10-29-2024
  • Dividend Yield
  • XLO N/A
  • BGFV 11.66%
  • EPS Growth
  • XLO N/A
  • BGFV N/A
  • EPS
  • XLO N/A
  • BGFV N/A
  • Revenue
  • XLO $4,620,000.00
  • BGFV $810,199,000.00
  • Revenue This Year
  • XLO N/A
  • BGFV $2.65
  • Revenue Next Year
  • XLO $428.64
  • BGFV N/A
  • P/E Ratio
  • XLO N/A
  • BGFV N/A
  • Revenue Growth
  • XLO N/A
  • BGFV N/A
  • 52 Week Low
  • XLO $0.49
  • BGFV $1.45
  • 52 Week High
  • XLO $1.93
  • BGFV $6.90
  • Technical
  • Relative Strength Index (RSI)
  • XLO 43.78
  • BGFV 44.17
  • Support Level
  • XLO $0.85
  • BGFV $1.55
  • Resistance Level
  • XLO $1.10
  • BGFV $1.84
  • Average True Range (ATR)
  • XLO 0.14
  • BGFV 0.10
  • MACD
  • XLO -0.04
  • BGFV -0.00
  • Stochastic Oscillator
  • XLO 12.81
  • BGFV 42.11

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune cell engagers (including tumor-activated cell engagers and tumor-activated effector-enhanced cell engagers).

About BGFV Big 5 Sporting Goods Corporation

Big 5 Sporting Goods Corp is a specialty retailer company that is principally engaged in the sale of sporting goods in the Western United States. Its product mix includes athletic shoes, apparel, and accessories, as well as a broad selection of outdoor and athletic equipment for team sports, fitness, camping, hunting, fishing, tennis, golf, winter and summer recreation and roller sports. The company operates solely as a sporting goods retailer, which includes both its retail stores and an e-commerce platform. The company operates a distribution center located in Riverside, California, that services all of its stores and e-commerce platform.

Share on Social Networks: